Filing metadata

Accession number
0001209191-22-012242
Form type
Form 3
Filer
Acer Therapeutics Inc.
CIK
CIK 1069308
Filed
Feb 23, 2022
Reporting period
Feb 21, 2022
Description
Initial ownership

Explore SEC Filings Hub